Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,976,818
+$837,370 QoQ
Shares Held
30,948
+18.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,150
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. MRK ranks #5 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
32,898 | $5,155,774 | |
| 2 | ABBV |
AbbVie Inc.
|
18,952 | $4,769,081 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
82,081 | $4,729,507 | |
| 4 | PFE |
Pfizer Inc
|
168,652 | $4,061,140 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
30,948 | $3,976,818 | |
| 6 | SNY |
Sanofi
|
85,773 | $3,659,076 | |
| 7 | JNJ |
Johnson & Johnson
|
7,395 | $1,878,108 | |
| 8 | LLY |
ELI LILLY & Co
|
602 | $722,056 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,976,818 | 30,948 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,139,448 | 26,099 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,854,756 | 27,121 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,326,385 | 111,121 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $8,013,683 | 101,234 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,141,142 | 90,699 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,485,571 | 75,247 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,177,503 | 10,369 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,283,682 | 10,369 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,429,018 | 10,830 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,180,686 | 10,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,032,691 | 10,031 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,138,899 | 9,870 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,054,324 | 9,910 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $3,888,686 | 35,049 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,296,845 | 38,282 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,441,120 | 37,744 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $7,370,141 | 89,825 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,225,313 | 81,228 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,070,315 | 80,819 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,608,383 | 72,115 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $5,231,098 | 67,857 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,941,126 | 60,405 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,873,148 | 58,748 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,021,084 | 51,999 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,004,109 | 52,042 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||